The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 04, 2014

Filed:

Aug. 11, 2011
Applicants:

Robert Settineri, Irvine, CA (US);

James F. Palmer, Newport Beach, CA (US);

Inventors:

Robert Settineri, Irvine, CA (US);

James F. Palmer, Newport Beach, CA (US);

Assignee:

Nutritional Therapeutics, Inc., Islandia, NY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 9/14 (2006.01); A01N 57/26 (2006.01); A61K 31/685 (2006.01); A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 31/66 (2006.01); A23D 9/013 (2006.01); A23L 1/30 (2006.01); A61K 31/683 (2006.01);
U.S. Cl.
CPC ...
A61K 31/66 (2013.01); A23D 9/013 (2013.01); A23L 1/3006 (2013.01); A23L 1/3014 (2013.01); A61K 31/683 (2013.01); A61K 31/70 (2013.01); A23V 2002/00 (2013.01); A23V 2250/184 (2013.01); Y10S 514/962 (2013.01); Y10S 514/96 (2013.01);
Abstract

Nutritional supplement formulations suitable for specific enhancement of cell and mitochondrial function comprise enriched formulations of phospholipids and chemical precursors containing specifically identified concentrations of phosphatidylglycerol, phosphatidic acid and phosphatidylcholine, and mitochondrial and cell membrane phospholipid molecules as well as other desirable constituents. Methods of enriching extracted sources of cell and mitochondrial membrane molecules and precursors from microbes, plants and other sources are also set forth. The formulae can be combined with nutritional, prebiotic, and probiotic (microbial) factors that increase bioavailability through the digestive tract and increase absorption at the cellular and subcellular levels. These lipid combinations can be used to treat mitochondrial disorders associated with medical pathologies, chronic illnesses and syndromes, or to maintain lipid balance for normal mitochondrial function, and can be administered in many different forms. The various combinations specifically enriched in the correct phospholipid and correct fatty acid residues can be used to treat organ, tissue, cell or system.


Find Patent Forward Citations

Loading…